Evidence map›Paper›PMID 30826399›Full record

ArticleDevelopmental biology2019

Human neural crest induction by temporal modulation of WNT activation.

Gustavo A Gomez, Maneeshi S Prasad, Nabjot Sandhu, Patrick B Shelar, Alan W Leung, Martín I García-Castro

Abstract read
In one paragraph

Article in Developmental biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modern In Vitro Techniques for Modeling Hearing Loss.Bioengineering (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. ChIP-Seq Protocol for In Vitro Cell Differentiation Systems.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gustavo A GomezDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA.
Maneeshi S PrasadDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA.
Nabjot SandhuDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA.
Patrick B ShelarDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA.
Alan W LeungDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA; Department of Genetics and Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA.
Martín I García-CastroDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA. Electronic address: martin.garcia-castro@ucr.edu.

Funding

Molecular Interactions During Neural Crest FormationR01DE017914 · NIDCR · YALE UNIVERSITY · PI GARCIA-CASTRO, MARTIN I. · 2007 to 2025
$6.3M
NIDCR NIH HHS R01 DE017914
6 · The paper itself

Abstract

The developmental biology of neural crest cells in humans remains unexplored due to technical and ethical challenges. The use of pluripotent stem cells to model human neural crest development has gained momentum. We recently introduced a rapid chemically defined approach to induce robust neural crest by WNT/β-CATENIN activation. Here we investigate the temporal requirements of ectopic WNT activation needed to induce neural crest cells. By altering the temporal activation of canonical WNT/β-CATENIN with a GSK3 inhibitor we find that a 2 Day pulse of WNT/β-CATENIN activation via GSK3 inhibition is optimal to generate bona fide neural crest cells, as shown by their capacity to differentiate to neural crest specific fates including peripheral neurons, glia, melanoblasts and ectomesenchymal osteocytes, chondrocytes and adipocytes. Although a 2 Day pulse can impart neural crest character when GSK3 is inhibited days after seeding, optimal results are obtained when WNT is activated from the beginning, and we find that the window of competence to induce NCs from non-neural ectodermal/placodal precursors closes by day 3 of culture. The reduced requirement for exogenous WNT activation offers an approach that is cost-effective, and we show that this adherent 2-dimensional approach is efficient in a broad range of culture platforms ranging from 96-well vessels to 10 cm dishes.

Indexed as

beta CateninCell DifferentiationCells, CulturedEctodermGene Expression Regulation, DevelopmentalGlycogen Synthase Kinase 3Human Embryonic Stem CellsHumansNeural CrestOsteogenesisPluripotent Stem CellsPyridinesPyrimidinesWnt ProteinsWnt Signaling Pathwaybeta CateninChir 99021CTNNB1 protein, humanGlycogen Synthase Kinase 3PyridinesPyrimidinesWnt ProteinsAdipocyteCHIRCHIR99021ChondrocyteGliaGSK3Human embryonic stem cellsMelanocytesNeural crestOsteoblastPeripheral neuronsPluripotent stem cellsSignalingSmooth muscleWNT

Identifiers

PMID30826399
PMCPMC6685424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.